Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 273, Issue 12, pp 4281–4287 | Cite as

Acute invasive fungal rhinosinusitis: our experience with 18 cases

  • Mehdi Bakhshaee
  • Amin Bojdi
  • Abolghasem Allahyari
  • Mohammad Reza Majidi
  • Sherwin Tavakol
  • Mohammad Javad Najafzadeh
  • Masoud Asghari
Rhinology

Abstract

Acute invasive fungal rhinosinusitis (AIFRS) is a rapidly progressive life threatening infection that is seen most commonly among immunocompromised patients. We present a case series of 18 patients clinically and histopathologically diagnosed with AIFRS with a mean follow-up of 9.11 ± 2.51 months (range 6–17). Demographic data, apparent symptoms and signs, underlying disorders, and outcomes are discussed. The mean age was 39.56 ± 20.66 years (range 2–75). The most common underlying diseases were diabetes mellitus (50 %) and leukemia (44.44 %). Mucosal biopsy confirmed fungal invasion of the nasal mucosa in all cases. The main fungi were Rhizopus oryzae (55.56 %), Absidia mucor (16.67 %), and Aspergillus fumigatus (27.78 %). Headache and facial pain (77.8 %), facial paresthesia (55.6 %), and ophthalmoplegia (33.3 %) were the most common symptoms and signs. Computed tomography and endoscopic findings showed various stages of sinonasal (100 %), pterygopalatine fossa (55.56 %), orbital (44.45 %), and cerebral (5.56 %) involvement. All patients underwent serial surgical debridement (3.78 ± 1.80 times; range 2–8) simultaneously with systemic antifungal therapy and proper management of the underlying disease. The most extreme case with brain involvement survived and recovered with no evidence of recurrent disease following treatment. All patients were considered cured after two endoscopic negative histopathologic evaluations. Three patients (16.67 %) died, one from uncontrolled leukemia and two due to renal failure. AIFRS is a potentially fatal condition, however, early diagnosis and management of the underlying disease accompanied with systemic antifungal and aggressive serial surgical intervention appears to be effective in reducing mortality in most patients.

Keywords

Invasive fungal rhinosinusitis Immunocompromised Diabetes mellitus Leukemia 

Notes

Compliance with ethical standards

Conflict of interest

None.

References

  1. 1.
    Momeni AK, Roberts CC, Chew FS (2007) Imaging of chronic and exotic sinonasal disease: review. AJR Am J Roentgenol 189(6):S35–S45CrossRefPubMedGoogle Scholar
  2. 2.
    Aribandi M, McCoy VA, Bazan C (2007) Imaging features of invasive and noninvasive fungal sinusitis: a review. Radiographics 27(5):1283–1296CrossRefPubMedGoogle Scholar
  3. 3.
    Gillespie MB, O’Malley BW, Francis HW (1998) An approach to fulminant invasive fungal rhinosinusitis in the immunocompromised host. Arch Otolaryngol Head Neck Surg 124(5):520–526CrossRefPubMedGoogle Scholar
  4. 4.
    Parikh SL, Venkatraman G, DelGaudio JM (2004) Invasive fungal sinusitis: a 15-year review from a single institution. Am J Rhinol 18(2):75–81PubMedGoogle Scholar
  5. 5.
    Abu El-Naaj I, Leiser Y, Wolff A, Peled M (2013) The surgical management of rhinocerebral mucormycosis. J Craniomaxillofac Surg 41(4):291–295CrossRefPubMedGoogle Scholar
  6. 6.
    Kursun E, Turunc T, Demiroglu YZ, Alışkan HE, Arslan AH (2015) Evaluation of 28 cases of mucormycosis. Mycoses 58(2):82–87CrossRefPubMedGoogle Scholar
  7. 7.
    Ketenci I, Unlü Y, Kaya H, Somdaş MA, Kontaş O, Oztürk M, Vural A (2011) Rhinocerebral mucormycosis: experience in 14 patients. J Laryngol Otol. 125(8):16CrossRefGoogle Scholar
  8. 8.
    Turner JH, Soudry E, Nayak JV, Hwang PH (2013) Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence. Laryngoscope 123(5):1112–1118CrossRefPubMedGoogle Scholar
  9. 9.
    Saedi B, Sadeghi M, Seilani P (2011) Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin B. J Laryngol Otol 125(8):807–810CrossRefPubMedGoogle Scholar
  10. 10.
    Bellazreg F, Hattab Z, Meksi S, Mansouri S, Hachfi W, Kaabia N, Ben Said M, Letaief A (2014) Outcome of mucormycosis after treatment: report of five cases. New Microbes New Infect 6:49–52CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Vaezi A, Moazeni M, Rahimi MT, de Hoog S, Badali H (2016) Mucormycosis in Iran: a systematic review. Mycoses. doi: 10.1111/myc.12474 (Epub ahead of print) PubMedGoogle Scholar
  12. 12.
    Kermani W, Bouttay R, Belcadhi M, Zaghouani H, Ben Ali M, Abdelkéfi M (2016) ENT mucormycosis. Report of 4 cases. Eur Ann Otorhinolaryngol Head Neck Dis 133(2):83–86. doi: 10.1016/j.anorl.2015.08.027 (Epub 2015 Sep 7) CrossRefPubMedGoogle Scholar
  13. 13.
    Mohammadi R, Meidani M, Mostafavizadeh K, Iraj B, Hamedani P, Sayedain SM, Mokhtari M (2015) Case series of rhinocerebral mucormycosis occurring in diabetic patients. Caspian J Intern Med 6(4):243–246 (Fall) PubMedPubMedCentralGoogle Scholar
  14. 14.
    Chen CY, Sheng WH, Cheng A, Chen YC, Tsay W, Tang JL, Huang SY, Chang SC, Tien HF (2011) Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan. BMC Infect Dis 22(11):250CrossRefGoogle Scholar
  15. 15.
    Mohindra S, Mohindra S, Gupta R, Bakshi J, Gupta SK (2007) Rhinocerebral mucormycosis: the disease spectrum in 27 patients. Mycoses 50(4):290–296CrossRefPubMedGoogle Scholar
  16. 16.
    Khor BS, Lee MH, Leu HS, Liu JW (2003) Rhinocerebral mucormycosis in Taiwan. J Microbiol Immunol Infect 36(4):266–269PubMedGoogle Scholar
  17. 17.
    Sun HY, Forrest G, Gupta KL, Aguado JM, Lortholary O, Julia MB, Safdar N, Patel R, Kusne S, Singh N (2010) Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients. Transplantation 90(1):85–92CrossRefPubMedGoogle Scholar
  18. 18.
    Kara IO, Tasova Y, Uguz A, Sahin B (2009) Mucormycosis-associated fungal infections in patients with haematologic malignancies. Int J Clin Pract 63(1):134–139CrossRefPubMedGoogle Scholar
  19. 19.
    Bhadada S, Bhansali A, Reddy KS, Bhat RV, Khandelwal N, Gupta AK (2005) Rhino-orbital-cerebral mucormycosis in type 1 diabetes mellitus. Indian J Pediatr 72(8):671–674CrossRefPubMedGoogle Scholar
  20. 20.
    Dhiwakar M, Thakar A, Bahadur S (2003) Improving outcomes in rhinocerebral mucormycosis—early diagnostic pointers and prognostic factors. J Laryngol Otol 117(11):861–865CrossRefPubMedGoogle Scholar
  21. 21.
    Bhansali A, Bhadada S, Sharma A, Suresh V, Gupta A, Singh P, Chakarbarti A, Dash RJ (2004) Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 80(949):670–674CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Mehdi Bakhshaee
    • 1
  • Amin Bojdi
    • 2
  • Abolghasem Allahyari
    • 3
  • Mohammad Reza Majidi
    • 4
  • Sherwin Tavakol
    • 5
  • Mohammad Javad Najafzadeh
    • 6
  • Masoud Asghari
    • 7
  1. 1.Sinus and Surgical Endoscopic Research Center, Faculty of MedicineMashhad University of Medical SciencesMashhadIran
  2. 2.Infectious Department, Faculty of MedicineMashhad University of Medical SciencesMashhadIran
  3. 3.Hematology-Oncology Department, Faculty of MedicineMashhad University of Medical SciencesMashhadIran
  4. 4.Otorhinolaryngology-Head and Neck Surgery, Faculty of MedicineMashhad University of Medical SciencesMashhadIran
  5. 5.Mashhad University of Medical SciencesMashhadIran
  6. 6.Medical Mycology, Faculty of MedicineMashhad University of Medical SciencesMashhadIran
  7. 7.Birjand University of MedicineBirjandIran

Personalised recommendations